Medicare Enrolled
Dr. Elvira Lindwall, M.D.
Rheumatology · Thousand Oaks, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lindwall from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lindwall?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lindwall
Dr. Elvira Lindwall is a rheumatology specialist in Thousand Oaks, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Lindwall performed 305,958 Medicare services across 2,867 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lindwall received a total of $103,280 from 63 pharmaceutical and/or device companies across 1867 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lindwall is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in CA
$103,280 industry payments
Medicare Practice Summary
Medicare Utilization ↗305,958
Medicare services
Top 1% in CA for rheumatology
2,867
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~16,998 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
124,800 | $4 | $10 |
| Tocilizumab injection (Actemra) | 71,830 | $5 | $11 |
| Romosozumab injection (Evenity) for osteoporosis | 38,220 | $8 | $30 |
| Denosumab injection (Prolia/Xgeva) | 35,640 | $19 | $40 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
11,670 | $10 | $50 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
8,990 | $26 | $198 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
7,975 | $34 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,378 | $103 | $214 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
1,007 | $68 | $157 |
| Hyaluronan intra-articular injection, 1 mg An injection of hyaluronan or its derivative into a joint space. This procedure delivers 1 mg of the substance directly into the affected joint. |
940 | $8 | $50 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
654 | $12 | $54 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
377 | $60 | $146 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
230 | $26 | $120 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
224 | $123 | $292 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
211 | $0 | $4 |
| New patient office visit, complex (60-74 min) | 162 | $170 | $406 |
| Injection, methylprednisolone acetate, 40 mg | 112 | $6 | $30 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
88 | $1 | $48 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
77 | $134 | $323 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
75 | $70 | $146 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
72 | $59 | $147 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
59 | $141 | $289 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
55 | $6 | $41 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
44 | $37 | $84 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
28 | $95 | $202 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
24 | $46 | $108 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
16 | $43 | $104 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.6% high complexity
89.5% medium
0.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$103,280
Total received (2018-2024)
Avg $14,754/year across 7 years
Top 8% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
1,867
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$70,383 (68.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,721 (29.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,176 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,313
2023
$21,836
2022
$14,167
2021
$20,291
2020
$24,330
2019
$10,790
2018
$3,553
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$3,500
ABBVIE INC.
$1,204
Amgen Inc.
$893
Janssen Biotech, Inc.
$499
Novartis Pharmaceuticals Corporation
$370
Radius Health, Inc.
$314
UCB, Inc.
$241
GlaxoSmithKline, LLC.
$204
PFIZER INC.
$192
AstraZeneca Pharmaceuticals LP
$160
ANI Pharmaceuticals, Inc.
$144
Azurity Pharmaceuticals, Inc.
$119
E.R. Squibb & Sons, L.L.C.
$96
Alexion Pharmaceuticals, Inc.
$88
Kiniksa Pharmaceuticals International, plc
$57
SCILEX PHARMACEUTICALS INC.
$45
Genentech USA, Inc.
$37
Fresenius Kabi USA, LLC
$29
SHORLA ONCOLOGY INC.
$28
Mallinckrodt Hospital Products Inc.
$28
Fidia Pharma USA Inc.
$26
Aurinia Pharma U.S., Inc.
$22
IBSA Pharma Inc.
$16
Top 3 companies account for 67.3% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$65,428
Amgen Inc.
$6,393
MEDEXUS PHARMA, INC.
$5,772
Janssen Biotech, Inc.
$4,036
ABBVIE INC.
$3,562
Novartis Pharmaceuticals Corporation
$2,544
GlaxoSmithKline, LLC.
$1,796
PFIZER INC.
$1,483
Radius Health, Inc.
$1,457
UCB, Inc.
$1,251
Horizon Therapeutics plc
$997
AbbVie Inc.
$831
AstraZeneca Pharmaceuticals LP
$805
AbbVie, Inc.
$694
E.R. Squibb & Sons, L.L.C.
$557
Celgene Corporation
$532
Alexion Pharmaceuticals, Inc.
$501
Genentech USA, Inc.
$467
GENZYME CORPORATION
$357
Mallinckrodt Enterprises LLC
$300
Azurity Pharmaceuticals, Inc.
$231
Aurinia Pharma U.S., Inc.
$200
Boehringer Ingelheim Pharmaceuticals, Inc.
$199
Horizon Pharma plc
$159
Merck Sharp & Dohme Corporation
$152
DePuy Synthes Sales Inc.
$152
Mallinckrodt LLC
$148
ANI Pharmaceuticals, Inc.
$144
Fidia Pharma USA Inc.
$139
Mallinckrodt Hospital Products Inc.
$131
Vertiflex, Inc.
$131
Takeda Pharmaceuticals U.S.A., Inc.
$130
Exeltis, USA Inc.
$128
Amarin Pharma Inc.
$128
Fresenius Kabi USA, LLC
$128
Almatica Pharma LLC
$118
Janssen Scientific Affairs, LLC
$86
SOBI, INC
$86
Kiniksa Pharmaceuticals, Ltd.
$80
ASSERTIO THERAPEUTICS, Inc.
$61
Gilead Sciences, Inc.
$59
Kiniksa Pharmaceuticals International, plc
$57
MEDAC PHARMA, INC.
$55
Zyla Life Sciences, Inc.
$52
Flexion Therapeutics, Inc.
$47
Egalet US Inc
$46
SCILEX PHARMACEUTICALS INC.
$45
Sobi, Inc
$38
Hikma Pharmaceuticals USA
$36
IBSA Pharma Inc.
$34
Zyla Life Sciences
$32
Antares Pharma, Inc.
$30
SHORLA ONCOLOGY INC.
$28
Octapharma USA, Inc.
$28
Organon LLC
$28
TerSera Therapeutics LLC
$27
Assertio Therapeutics, Inc.
$27
Arbor Pharmaceuticals, Inc.
$24
ARBOR PHARMACEUTICALS, INC.
$23
Alnylam Pharmaceuticals Inc.
$22
Novo Nordisk Inc
$18
Eyevance Pharmaceuticals LLC
$16
Ultragenyx Pharmaceutical Inc.
$14
Top 3 companies account for 75.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Access · Actemra · Aimovig · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CRYSVITA · CYLTEZO · Cimzia · EVENITY · EVUSHELD · Enbrel · FORTEO · GRALISE · Gralise · HORIZANT · HUMIRA · HYMOVIS · Horizant · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LICART · LUPKYNIS · LYRICA · MONOVISC · Mitigare · NAPRELAN · NELARABINE · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ONPATTRO · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · QMIIZ ODT · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · Strensiq · Superion ISS · TALTZ · TAVNEOS · TEPEZZA · TREMFYA · TRINTELLIX · Tavneos · Tirosint · Tobradex ST · Trintellix · Tymlos · Uloric · VIMOVO · Vascepa · Wegovy · XELJANZ · ZIPSOR · ZORVOLEX · ZTLido · Zilretta · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for rheumatology in CA.
Geographic Context
Rheumatologists within 10 mi
35
Per 100K population
4.2
County median income
$107,327
Nearest hospital
LOS ROBLES HOSPITAL & MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lindwall is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with speaking/promotional industry engagement in the top 8% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lindwall experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Lindwall performed 124,800 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lindwall receive payments from pharmaceutical companies?
Yes. Dr. Lindwall received a total of $103,280 from 63 companies across 1,867 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lindwall's costs compare to other rheumatologists in Thousand Oaks?
Dr. Lindwall's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lindwall) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Thousand Oaks
Browse rheumatologists in Thousand Oaks ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in CA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in CA
Which CA rheumatologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
MEDEXUS PHARMA, INC. Payments to Doctors
See all physicians who received payments from MEDEXUS PHARMA, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology